Vaxart, Inc. (VXRT) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $24.00K; Additional Paid in Capital, Common StockUSD $550.96M; Treasury Stock, Common, ValueUSD $90.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $24.00K; Additional Paid in Capital, Common StockUSD $549.61M; Treasury Stock, Common, ValueUSD $497.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $24.00K; Additional Paid in Capital, Common StockUSD $548.13M; Treasury Stock, Common, ValueUSD $159.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $23.00K; Additional Paid in Capital, Common StockUSD $542.35M; Treasury Stock, Common, ValueUSD $371.00K.
Vaxart, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares, Acquired shares | Treasury Stock Acquired, Average Cost Per Share USD/shares | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $24.00K | $550.96M | $90.00K | $-11.00K | $-468.51M | $82.37M | 137.68K | 3 month · $26.00K 6 month · $364.00K | 3 month · $167.00K 6 month · $167.00K | 3 month · $1.29M 6 month · $2.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $24.00K | $549.61M | $497.00K | $-7.00K | $-455.02M | $94.12M | 755.08K | 3 month · $338.00K | (m) | 3 month · $1.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $24.00K | $548.13M | $159.00K | $-3.00K | $-460.19M | $87.80M | 248.09K | 12 month · $199.00K | (m) | 12 month · $8.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $23.00K | $542.35M | $371.00K | $-2.00K | $-515.24M | $26.76M | 514.65K | 3 month · $4.00K 9 month · $178.00K | (m) | 3 month · $2.02M 9 month · $6.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $23.00K | $540.33M | $367.00K | $-7.00K | $-507.10M | $32.88M | 504.57K | 3 month · $7.00K 6 month · $174.00K | 3 month · $174.00K 6 month · $174.00K | 3 month · $2.12M 6 month · $4.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $23.00K | $538.23M | $517.00K | $-7.00K | $-492.11M | $45.62M | 702.78K | 3 month · $167.00K | (m) | 3 month · $2.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $23.00K | $535.77M | $350.00K | $4.00K | $-476.52M | $58.92M | 429.55K | 12 month · $214.00K | (m) | 12 month · $11.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $23.00K | $533.50M | $574.00K | $27.00K | $-464.54M | $68.44M | 700.12K | 3 month · $9.00K 9 month · $208.00K | 3 month · $10.00K | 3 month · $2.48M 9 month · $9.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $23.00K | $531.03M | $565.00K | $-16.00K | $-450.46M | $80.01M | 688.33K | 3 month · $17.00K 6 month · $199.00K | (m) | 3 month · $2.56M 6 month · $6.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $18.00K | $490.22M | $548.00K | $-10.00K | $-433.99M | $55.69M | 664.92K | 3 month · $182.00K | (m) | 3 month · $4.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $15.00K | $467.73M | $366.00K | $-1.00K | $-409.57M | $57.80M | 507.02K | 12 month · $366.00K | (m) | 12 month · $14.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $15.00K | $463.75M | $39.00K | $-11.00K | $-392.20M | $71.52M | 43.84K | 3 month · $8.00K 9 month · $39.00K | (m) | 3 month · $3.84M 9 month · $10.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $15.00K | $459.91M | $31.00K | $-24.00K | $-374.80M | $85.07M | 33.25K | 3 month · $21.00K 6 month · $31.00K | (m) | 3 month · $3.93M 6 month · $6.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $14.00K | $442.07M | $10.00K | $-70.00K | $-352.25M | $89.75M | 13.55K | 3 month · $10.00K | 3 month · $103.00K | 3 month · $2.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $13.00K | $437.99M | $0.00 | $-299.00K | $-327.11M | $110.60M | 0.00 | (m) | 12 month · $786.00K | 12 month · $13.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $13.00K | $426.00M | (m) | $-518.00K | $-303.19M | $122.31M | (m) | (m) | 3 month · $161.00K 9 month · $583.00K | 3 month · $3.64M 9 month · $10.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $13.00K | $417.37M | (m) | $-409.00K | $-273.88M | $143.09M | (m) | (m) | 6 month · $422.00K | 3 month · $3.42M 6 month · $6.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $13.00K | $411.11M | (m) | $-309.00K | $-244.45M | $166.37M | (m) | (m) | 3 month · $314.00K | 3 month · $3.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $13.00K | $406.94M | (m) | $-74.00K | $-219.35M | $187.53M | (m) | (m) | 12 month · $5.75M | 12 month · $8.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $13.00K | $403.52M | (m) | $-3.00K | $-198.59M | $204.95M | (m) | (m) | 3 month · $746.00K 9 month · $5.75M | 3 month · $2.10M 9 month · $5.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $12.00K | $380.78M | (m) | $-9.00K | $-181.00M | $199.78M | (m) | (m) | 3 month · $1.82M 6 month · $5.01M | 3 month · $2.60M 6 month · $3.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $12.00K | $341.12M | (m) | $-5.00K | $-164.89M | $176.24M | (m) | (m) | (m) | 3 month · $1.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $11.00K | $272.27M | (m) | $0.00 | $-148.88M | $123.40M | (m) | (m) | (m) | 12 month · $4.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $11.00K | $266.69M | (m) | (m) | $-135.02M | $131.68M | (m) | (m) | 3 month · $2.97M 9 month · $2.97M | 3 month · $915.00K 9 month · $3.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $10.00K | $167.16M | (m) | (m) | $-126.94M | $40.23M | (m) | (m) | 6 month · $1.28M | 3 month · $2.86M 6 month · $2.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $7.20M | $142.05M | (m) | (m) | $-117.96M | $31.29M | (m) | (m) | (m) | 3 month · $96.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $5.00K | $129.61M | (m) | (m) | $-116.66M | $12.95M | (m) | (m) | 12 month · $560.00K | 12 month · $627.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $4.62M | $124.53M | (m) | (m) | $-110.25M | $18.90M | (m) | (m) | 9 month · $560.00K | 3 month · $146.00K 9 month · $490.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.58M | $119.26M | (m) | (m) | $-104.99M | $15.85M | (m) | (m) | 3 month · $1.58M 6 month · $560.00K | 3 month · $180.00K 6 month · $344.00K | (m) | (m) | (m) | 3 month · $333.00K | (m) | (m) | (m) |
| 2019-03-31 | (m) | $834.00K | $111.10M | (m) | (m) | $-99.36M | $12.58M | (m) | (m) | 3 month · $560.00K | 3 month · $164.00K | (m) | (m) | (m) | 3 month · $100.00K | (m) | (m) | (m) |
| 2018-12-31 | (m) | $714.00K | $108.51M | (m) | (m) | $-97.99M | $11.21M | (m) | (m) | (m) | 12 month · $539.00K | (m) | (m) | (m) | 12 month · $70.00K | (m) | (m) | (m) |
| 2018-09-30 | (m) | $714.00K | $108.36M | (m) | (m) | $-93.09M | $15.99M | (m) | (m) | (m) | 3 month · $183.00K 9 month · $387.00K | (m) | (m) | (m) | 9 month · $70.00K | (m) | (m) | (m) |
| 2018-06-30 | (m) | $714.00K | $108.18M | (m) | (m) | $-86.54M | $22.35M | (m) | (m) | (m) | 3 month · $118.00K 6 month · $204.00K | (m) | (m) | (m) | 6 month · $70.00K | (m) | (m) | (m) |
| 2018-03-31 | (m) | $714.00K | $108.06M | (m) | (m) | $-77.67M | $31.11M | (m) | (m) | (m) | 3 month · $86.00K | (m) | (m) | (m) | 3 month · $70.00K | (m) | (m) | (m) |
| 2017-12-31 | $1.00K | $3.90M | $41.26M | (m) | $19.00M | $-79.98M | $-38.72M | (m) | (m) | (m) | 6 month · $800.00K 12 month · $477.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $3.90M | $160.10M | (m) | $19.00M | $-169.10M | $13.90M | (m) | (m) | (m) | 3 month · $500.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $3.90M | $159.60M | (m) | $19.00M | $-163.80M | $18.70M | (m) | (m) | (m) | 12 month · $1.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $3.90M | $159.10M | (m) | $19.00M | $-157.80M | $24.20M | (m) | (m) | (m) | 9 month · $1.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $3.90M | $158.50M | (m) | $19.00M | $-153.40M | $-29.64M | (m) | (m) | (m) | 6 month · $900.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $3.90M | $158.00M | (m) | $19.00M | $-144.30M | $36.60M | (m) | (m) | (m) | 3 month · $400.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $3.90M | $157.60M | (m) | $19.00M | $-134.30M | $46.20M | (m) | (m) | (m) | 12 month · $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $3.90M | $157.20M | (m) | $18.90M | $-127.30M | $52.70M | (m) | (m) | (m) | 9 month · $1.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $3.90M | $156.80M | (m) | $18.90M | $-122.10M | $57.50M | (m) | (m) | (m) | 6 month · $1.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $3.90M | $156.20M | (m) | $18.90M | $-115.50M | $63.50M | (m) | (m) | (m) | 3 month · $600.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $3.90M | $155.60M | (m) | $18.90M | $-108.90M | $69.50M | (m) | (m) | (m) | 12 month · $2.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $3.50M | $148.00M | (m) | (m) | $-89.00M | $81.50M | (m) | (m) | (m) | (m) | (m) | $19.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $3.50M | $147.40M | (m) | (m) | $-90.20M | $82.40M | (m) | (m) | (m) | 6 month · $1.00M | (m) | $21.70M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $3.50M | $146.80M | (m) | (m) | $-96.70M | $77.90M | (m) | (m) | (m) | 3 month · $400.00K | (m) | $24.30M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $3.50M | $146.40M | (m) | $26.80M | $-89.80M | $86.90M | (m) | (m) | (m) | 12 month · $1.40M | (m) | $26.80M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $3.50M | $146.20M | (m) | (m) | $-79.60M | $96.00M | (m) | (m) | (m) | (m) | (m) | $25.90M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $2.80M | $119.60M | (m) | (m) | $-82.80M | $64.20M | (m) | (m) | (m) | (m) | (m) | $24.60M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $2.80M | $119.00M | (m) | (m) | $-82.50M | $64.90M | (m) | (m) | (m) | (m) | (m) | $25.60M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $2.80M | $118.70M | (m) | (m) | $-78.80M | $68.00M | (m) | (m) | (m) | 12 month · $2.60M | (m) | $25.30M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $3.42M | $234.78M | (m) | (m) | $-72.10M | $80.10M | (m) | (m) | (m) | (m) | $117.05M | $31.05M | (m) | (m) | (m) | (m) | 5.87M |
| 2012-12-31 | (m) | $3.42M | $234.38M | (m) | (m) | $-72.31M | $78.96M | (m) | (m) | (m) | (m) | $117.05M | $30.52M | (m) | (m) | (m) | (m) | 5.87M |
| 2012-09-30 | (m) | $6.36M | $376.00M | (m) | (m) | $-235.34M | $29.97M | (m) | (m) | (m) | (m) | $117.05M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $24.50M | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 14.55M | 1 month · 1.68 | (m) |
| 2012-06-30 | (m) | $100.40M | $700.00K | (m) | (m) | $-69.90M | $59.30M | (m) | 12 month · $-400.00K | (m) | 12 month · $500.00K | $1.40M | $29.50M | (m) | (m) | (m) | (m) | 1.82M |
| 2012-03-31 | (m) | $6.36M | $374.13M | (m) | (m) | $-228.51M | $59.41M | (m) | (m) | (m) | (m) | $92.57M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $6.36M | $373.16M | (m) | (m) | $-228.08M | $67.39M | (m) | (m) | (m) | (m) | $92.57M | (m) | (m) | (m) | (m) | (m) | 20.70M |
| 2011-09-24 | (m) | $6.36M | $372.99M | (m) | $-1.00K | $-226.09M | $60.69M | (m) | (m) | (m) | (m) | $92.57M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $81.40M | (m) | 12 month · $-800.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-25 | (m) | $6.36M | $372.07M | (m) | $3.00K | $-226.17M | $59.70M | (m) | (m) | (m) | (m) | $92.57M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-25 | (m) | $6.32M | $370.37M | (m) | $-3.00K | $-223.55M | $60.57M | (m) | 12 month · $42.30M | (m) | (m) | $92.57M | (m) | (m) | (m) | (m) | (m) | 20.70M |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $87.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-26 | (m) | (m) | (m) | (m) | (m) | (m) | $97.41M | (m) | 12 month · $8.08M | (m) | (m) | (m) | (m) | 12 month · $-79.00K | (m) | (m) | (m) | (m) |
| 2008-12-27 | (m) | (m) | (m) | (m) | (m) | (m) | $121.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |